Plant-based anticancer molecules: A chemical and biological profile of some important leads

被引:283
作者
Srivastava, V [1 ]
Negi, AS [1 ]
Kumar, JK [1 ]
Gupta, MM [1 ]
Khanuja, SPS [1 ]
机构
[1] CIMAP, Lucknow 226015, Uttar Pradesh, India
关键词
anticancer; camptothecin; taxol; combretastatin A4; podophyllotoxin;
D O I
10.1016/j.bmc.2005.05.066
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of natural products, with diverse chemical structures, have been isolated as anticancer agents. Several potential lead molecules such as camptothecin, vincristine, vinblastine, taxol, podophyllotoxin, combretastatins, etc. have been isolated from plants and many of them have been modified to yield better analogues for activity, toxicity or solubility. Several successful molecules like topotecan, irinotecan, taxotere, etoposide, teniposide, etc. also have emerged as drugs upon modification of these natural leads and many more are yet to come. In this review, the authors have focused on four important anticancer leads, that is, camptothecin, taxol, combretastatin A-4 and podophyllotoxin. Their chemistry, structure and activity relationships, biological activities, modes of action, analogue synthesis and future prospects have been discussed. (c) 2005 Published by Elsevier Ltd.
引用
收藏
页码:5892 / 5908
页数:17
相关论文
共 104 条
[21]   INVITRO EVALUATION OF THE ANTINEOPLASTIC ACTIVITY OF COMBRETASTATIN-A-4, A NATURAL PRODUCT FROM COMBRETUM-CAFFRUM (ARID SHRUB) [J].
ELZAYAT, AAE ;
DEGEN, D ;
DRABEK, S ;
CLARK, GM ;
PETTIT, GR ;
VONHOFF, DD .
ANTI-CANCER DRUGS, 1993, 4 (01) :19-25
[22]  
EMERSON DL, 1995, CANCER RES, V55, P603
[23]  
FUCHS DA, 1978, CANCER TREAT REP, V62, P1219
[24]  
Fulvia O., 1997, CARBOHYD RES, V301, P95
[25]  
GEORG GI, 1994, TAXOL SCI APPL
[26]   Antitumor properties of podophyllotoxin and related compounds [J].
Gordaliza, M ;
Castro, MA ;
del Corral, JMM ;
San Feliciano, A .
CURRENT PHARMACEUTICAL DESIGN, 2000, 6 (18) :1811-1839
[27]   Clinical evidence for topotecan-paclitaxel non-cross-resistance in ovarian cancer [J].
Gore, M ;
Huinink, WT ;
Carmichael, J ;
Gordon, A ;
Davidson, N ;
Coleman, R ;
Spaczynski, M ;
Héron, JF ;
Bolis, G ;
Malmström, H ;
Malfetano, J ;
Scarabelli, C ;
Vennin, P ;
Ross, G ;
Fields, SZ .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (07) :1893-1900
[28]   In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug [J].
Grosios, K ;
Holwell, SE ;
McGown, AT ;
Pettit, GR ;
Bibby, MC .
BRITISH JOURNAL OF CANCER, 1999, 81 (08) :1318-1327
[29]   Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin [J].
Guianvarc'h, D ;
Duca, M ;
Boukarim, C ;
Kraus-Berthier, L ;
Léonce, S ;
Pierré, A ;
Pfeiffer, B ;
Renard, P ;
Arimondo, PB ;
Monneret, C ;
Dauzonne, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (09) :2365-2374
[30]   Novel sulfonate analogues of combretastatin A-4: Potent antimitotic agents [J].
Gwaltney, SL ;
Imade, HM ;
Barr, KJ ;
Li, Q ;
Gehrke, L ;
Credo, RB ;
Warner, RB ;
Lee, JY ;
Kovar, P ;
Wang, JY ;
Nukkala, MA ;
Zielinski, NA ;
Frost, D ;
Ng, SC ;
Sham, HL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (07) :871-874